Bordetella Pertussis Test Market is Anticipated to Reach USD 500.0 Million, at a Notable 5.9% CAGR by 2035

WiseGuy Reports, Oct. 2025 (Press Release) – The Bordetella Pertussis Test Market Global Outlook:

Global Bordetella Pertussis Test Market Growth Analysis and Trends Report Test Type (PCR Testing, Serological Testing, Culture Testing, Antigen Testing), By Product Type (Reagents, Kits, Instruments), By End User (Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings), By Technology (Molecular Diagnostics, Immunodiagnostics, Microbial Culture) and By Regions – Global Industry Forecast 2025 to 2035

Bordetella Pertussis Test Market Overview

Bordetella Pertussis Test Market: Advancing Diagnostic Solutions for Pertussis Management

The Bordetella Pertussis Test Market is poised for significant growth as healthcare systems worldwide focus on timely diagnosis and management of pertussis, commonly known as whooping cough. Valued at USD 266.4 million in 2024, the market is projected to reach USD 500.0 million by 2035, expanding at a CAGR of 5.9% during 2025–2035. Rising prevalence of pertussis, increasing awareness about the disease, and continuous advancements in diagnostic technologies are driving adoption across clinical laboratories, hospitals, and point-of-care settings.

Request To Free Sample of This Strategic Report –

https://www.wiseguyreports.com/sample-request?id=742552

Market Overview and Dynamics

Bordetella pertussis, a highly contagious respiratory pathogen, poses a major public health concern, particularly for infants, young children, and immunocompromised individuals. Early and accurate detection is crucial for disease management, outbreak control, and vaccination monitoring. The Bordetella Pertussis Test Market is witnessing robust growth due to the increasing adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR) and real-time PCR, which provide rapid and precise results.

Government initiatives promoting routine immunization and respiratory disease screening are further boosting market growth. Supportive healthcare policies, combined with increasing expenditure on diagnostics infrastructure, have enabled widespread access to pertussis testing. Moreover, awareness campaigns emphasizing the importance of early detection and preventive healthcare are encouraging healthcare providers to adopt comprehensive testing strategies.

🛒 Buy Now Premium Research Report –

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=742552

Market Segmentation Analysis

The Bordetella Pertussis Test Market is segmented based on test type, product type, end user, technology, and region.

By Test Type: The market includes molecular tests, serological tests, and culture-based tests. Molecular tests, particularly PCR-based assays, dominate due to high sensitivity, specificity, and faster turnaround time, making them ideal for clinical diagnostics.
By Product Type: The segment comprises kits, reagents, instruments, and consumables. Test kits hold the largest share as they offer convenience, standardization, and scalability for laboratories and hospitals. Instruments and reagents are witnessing steady growth due to increasing adoption of automated testing systems.
By End User: Hospitals, diagnostic laboratories, and point-of-care centers are key end users. Hospitals remain the leading segment owing to availability of trained personnel and comprehensive diagnostic infrastructure. Point-of-care testing is emerging rapidly, supported by the need for rapid diagnostics in remote and underserved regions.
By Technology: PCR, real-time PCR, ELISA, and immunoassays are major technologies used for Bordetella pertussis detection. PCR and real-time PCR are preferred for their accuracy, speed, and ability to detect low bacterial loads, while immunoassays are gaining adoption in point-of-care and resource-limited settings.

Regional Insights

The Bordetella Pertussis Test Market exhibits diverse growth patterns across regions.

North America dominates the market, led by the U.S., due to high healthcare expenditure, advanced laboratory infrastructure, and strong adoption of molecular diagnostic tools. Rising awareness of pertussis among caregivers and healthcare providers also contributes to market growth.
Europe holds a significant share, with Germany, the UK, and France driving demand through government vaccination programs, routine respiratory disease screening, and availability of advanced diagnostic platforms.
Asia-Pacific (APAC) is poised for rapid growth, supported by increasing healthcare investments, rising prevalence of respiratory infections, and improving access to diagnostic facilities in China, India, and Japan.
South America and MEA are emerging markets with increasing adoption of point-of-care testing and diagnostic kits, supported by government initiatives and growing healthcare infrastructure.

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures)

https://www.wiseguyreports.com/reports/bordetella-pertussi-test-market

Key Market Drivers and Opportunities

The Bordetella Pertussis Test Market is propelled by multiple factors:

Rising prevalence of pertussis, particularly among infants and children, drives the need for timely diagnosis.
Increasing awareness of the importance of diagnostic testing among healthcare providers and patients.
Technological advancements in molecular diagnostics and automation enhance testing efficiency and accuracy.
Supportive government initiatives promoting vaccination, respiratory disease management, and screening programs.
Growing healthcare expenditure and investment in laboratory infrastructure improve accessibility and adoption.

Key opportunities lie in expanding point-of-care testing, developing multiplex assays for simultaneous detection of multiple respiratory pathogens, and leveraging AI-based diagnostic solutions for faster and more precise results. Growth in immunization programs and public health initiatives targeting respiratory diseases further enhances market potential.

Competitive Landscape

The Bordetella Pertussis Test Market is competitive, with major players focusing on innovation, product expansion, and strategic collaborations. Leading companies include:

Grifols
Siemens Healthineers
Danaher Corporation
Agilent Technologies
Roche
PerkinElmer
Abbott Laboratories
Cepheid
Fujirebio
GenMark Diagnostics
bioMérieux
Becton Dickinson
Thermo Fisher Scientific
Meridian Bioscience
Quidel Corporation
Hologic

These companies are investing in R&D to develop high-performance, rapid, and multiplex diagnostic kits. Strategic partnerships and collaborations with healthcare institutions and research organizations are enhancing market penetration and technology adoption.

Future Outlook

The Bordetella Pertussis Test Market is expected to sustain strong growth through 2035, driven by rising disease prevalence, increased awareness, and technological advancements. Adoption of rapid molecular diagnostics, expansion of point-of-care testing, and integration with digital health platforms will redefine pertussis management and improve patient outcomes. With growing emphasis on preventive healthcare and immunization, the market presents substantial opportunities for diagnostics companies to expand globally.

Reasons To Buy The Bordetella Pertussis Test Market Report:

➼ In-depth analysis of the Bordetella Pertussis Test Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

African Trypanosomiasis Market

Heel Pads Market

Anorexia Nervosa Treatment Market